In Vivo is part of Pharma Intelligence UK Limited
This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.
Pfizer and GlaxoSmithKline set up HIV joint venture
11 Jun 2014
In a move that gives them 19% of the global HIV market, GlaxoSmithKline and Pfizer have set up a joint venture to focus on 17 of their marketed drugs and pipeline compounds for this infectious disease. Together the assets have an estimated book value of £250mm ($373mm). Some analysts say the yet-unnamed new entity may likely be spun off or sold in the future.
R&D and Marketing (Licensing)
Already a Biomedtracker subscriber?You have access to the full deal record through your subscription
Want to become a subscriber?Subscribers get more deal details, updates, deal financials and deal products.Questions?